Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival

被引:19
|
作者
Mastroianni, Riccardo [1 ,2 ]
Brassetti, Ado [1 ]
Krajewski, Wojciech [3 ]
Zdrojowy, Romuald [3 ]
Al Salhi, Yazan [4 ]
Anceschi, Umberto [1 ]
Bove, Alfredo Maria [1 ]
Carbone, Antonio [4 ]
De Nunzio, Cosimo [5 ]
Fuschi, Andrea [4 ]
Ferriero, Mariaconsiglia [1 ]
Nacchia, Antonio [5 ]
Pastore, Antonio Luigi [4 ]
Tema, Giorgia [5 ]
Tuderti, Gabriele [1 ]
Gallucci, Michele [2 ]
Simone, Giuseppe [1 ]
机构
[1] Regina Elena Inst Canc Res, Dept Urol, Via Elio Chianesi 53, I-00154 Rome, RM, Italy
[2] Sapienza Univ, Dept Urol, Rome, Italy
[3] Wroclaw Med Univ, Dept Urol & Urol Oncol, Wroclaw, Poland
[4] Sapienza Univ ICOT, Dept Medico Surg Sci & Biotechnol, Urol Unit, Latina, Italy
[5] St Andrea Hosp, Dept Urol, Rome, Italy
来源
EUROPEAN UROLOGY FOCUS | 2021年 / 7卷 / 06期
关键词
Non-muscle-invasive bladder cancer; Detrusor muscle; Transurethral resection of the bladder; Recurrence-free survival; Low-risk bladder cancer; Intermediate-risk bladder cancer; Low-grade bladder cancer; TRANSURETHRAL RESECTION; EUROPEAN ORGANIZATION; INDIVIDUAL PATIENTS; PROGNOSTIC-FACTORS; STAGE TA; CANCER; RISK; CLASSIFICATION; PROGRESSION; NEOPLASMS;
D O I
10.1016/j.euf.2020.08.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Obtaining detrusor muscle (DM) in transurethral resection of bladder tumor (TURBt) specimen is considered a surrogate marker of resection quality. However, evidence was principally investigated in high-risk tumors. Therefore, DM sampling for low-grade (LG) urothelial carcinoma (UC) remains poorly investigated and certainly requires further investigation. Objective: To assess whether the absence of DM in TURBt specimen has a negative impact on recurrence-free survival (RFS) in patients with a Ta LG UC. Design, setting, and participants: A multicenter TURBt database was queried for "LG, Ta, UC of the bladder." All patients treated between 1996 and 2018 with tumor grade assessed according to both 1973 World Health Organization and 2004 WHO/International Society of Urological Pathology grading classifications and with a minimum follow-up of 1 yr were included. Patients with a previous history of high-grade UC, upper urinary tract UC, or bladder tumor differentiations other than UC were excluded. Intervention: TURBt. Outcome measurements and statistical analysis: Baseline demographic, clinical, and pathologic data were analyzed. The European Organization for Research and Treatment of Cancer (EORTC) risk group was recorded. Kaplan-Meier analysis was performed to assess the predictive role of clinical and pathologic data for RFS. Univariable and multivariable Cox regression analyses were performed to identify the predictors of recurrence. Results and limitations: Overall, 521 patients were included. At Kaplan-Meier analysis, the low-risk cohort displayed significantly higher RFS than the intermediate-risk cohort (1-yr RFS 87% vs 79%; log-rank p = 0.007). At univariable Cox regression analysis, only gender, multiple tumors, tumor diameter >= 3 cm, and EORTC risk group were significant predictors of recurrence. Absence of DM had no impact on RFS. Multivariable Cox regression analysis confirmed gender and EORTC risk group as independent predictors of recurrence. Conclusions: Absence of DM in TURBt specimen has negligible role in RFS of patients with Ta LG tumors of the bladder. Patient summary: In this study, we assessed the role that detrusor muscle (DM) in transurethral resection of bladder tumor specimen has in recurrence-free survival, in patients with a Ta low-grade urothelial carcinoma of the bladder. Absence of DM has no impact on tumor recurrence; therefore, it does not require additional attention. (C) 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1324 / 1331
页数:8
相关论文
共 50 条
  • [1] Predicting factors for recurrence in low-grade Ta primary bladder tumours
    Molina Escudero, R.
    Alvarez Ardura, M.
    Ripalda Ferretti, E.
    Crespo Martinez, L.
    Gonzalez Avila, N.
    Dorado Valentin, M.
    Paez Borda, A.
    ARCHIVOS ESPANOLES DE UROLOGIA, 2014, 67 (06): : 541 - 548
  • [2] Low-grade Ta (noninvasive) urothelial carcinoma of the bladder
    Oosterlinck, W
    Solsona, E
    Akaza, H
    Busch, C
    Goebell, PJ
    Malmström, PU
    Özen, H
    Sved, P
    UROLOGY, 2005, 66 (6A) : 75 - 89
  • [3] Development of a predictive model for recurrence-free survival in pTa low-grade bladder cancer
    Daza, Jorge
    Grauer, Ralph
    Chen, Sophie
    Lavalle, Etienne
    Razdan, Shirin
    Dey, Linda
    Steineck, Gunnar
    Renstrom-Koskela, Lotta
    Li, Qiang
    Hussein, Ahmed A.
    Mehrazin, Reza
    Waingankar, Nikhil
    Guru, Khurshid
    Wiklund, Peter
    Sfakianos, John P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) : 256.e9 - 256.e15
  • [4] Clinicopathological analysis of recurrence and progression of low-grade papillary urothelial carcinoma of the urinary bladder: Predicting the outcome
    Bahmad, Hisham F.
    Lopez, Olga
    Moreno, Juan Carlos Alvarez
    Lopez, Kalei
    Malik, Fayeza
    Salami, Ali
    Nieder, Alan M.
    Omarzai, Yumna
    Poppiti, Robert J.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 61
  • [5] Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma
    Milojevic, Bogomir
    Janicic, Aleksandar
    Milojevic, Isidora Grozdic
    Grubor, Nikola
    Bumbasirevic, Uros
    Radovanovic, Milan
    Radisavcevic, Djordje
    Jovanovic, Darko
    Sretenovic, Milan
    Durutovic, Otas
    Grujicic, Sandra Sipetic
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2538 - 2544
  • [6] Single-Dose Post-Office Fulguration Mitomycin C Instillation Appears to Improve Recurrence-Free Survival in Patients With Low-Grade Noninvasive Bladder Cancer
    Halstuch, Daniel
    Lotan, Paz
    Karchever, Idan
    Rubinshtein, Dor
    Kedar, Daniel
    Baniel, Jack
    Golan, Shay
    CLINICAL GENITOURINARY CANCER, 2023, 21 (05) : E320 - E325
  • [7] Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma
    Krpina, Kristian
    Babarovic, Emina
    Jonjic, Nives
    VIRCHOWS ARCHIV, 2015, 467 (04) : 443 - 448
  • [8] Cytologic and cystoscopic predictors of recurrence and progression in patients with low-grade urothelial carcinoma
    Jackson, Julie
    Barkan, Gueliz A.
    Kapur, Umesh
    Wojcik, Eva M.
    CANCER CYTOPATHOLOGY, 2013, 121 (07) : 398 - 402
  • [9] Conditional Intravesical Recurrence-Free Survival Rate After Radical Nephroureterectomy With Bladder Cuff Excision for Upper Tract Urothelial Carcinoma
    Chung, Jae Hoon
    Song, Wan
    Kang, Minyong
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Sung, Hyun Hwan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Impact on oncological outcomes of detrusor muscle absence in pTaHG urothelial carcinoma of the bladder? The end of the “jump” of the lamina propria layer myth
    Gabrielle Tissot
    Pierre-Etienne Gabriel
    Ulysse Dubuet
    Sophie Régnier
    Idir Ouzaid
    Marco Moschini
    Francesco Soria
    David D’Andrea
    Shahrokh F. Shariat
    Alexandra Budowski
    Cédric Poyet
    Mathieu Roumiguie
    Mario Alvarez Maestro
    Alberto Briganti
    Wojciech Krajewski
    Kees Hendricksen
    Hans Veerman
    Luca Afferi
    Agostino Mattei
    Carlo Di Bona
    Stefania Zamboni
    Claudio Simeone
    Ronan Thenault
    Gregory Verhoest
    Jean-François Hermieu
    Evanguelos Xylinas
    World Journal of Urology, 43 (1)